Atreya Dash

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor
    Atreya Dash
    Department of Urology and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 112:800-5. 2008
  2. ncbi request reprint Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm
    Atreya Dash
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BJU Int 97:939-45. 2006
  3. ncbi request reprint Comorbidity and competing risks for mortality in men with prostate cancer
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, USA
    Cancer 117:4642-50. 2011
  4. pmc A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience
    Atreya Dash
    Division of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 113:2471-7. 2008
  5. doi request reprint Consideration of comorbidity in risk stratification prior to prostate biopsy
    Michael A Liss
    Department of Urology, University of California at Irvine, Irvine, California, USA
    Cancer 119:2413-8. 2013
  6. doi request reprint Improved prediction of long-term, other cause mortality in men with prostate cancer
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095 1738, USA
    J Urol 186:1868-73. 2011
  7. pmc Copy number and gene expression differences between African American and Caucasian American prostate cancer
    Amy E Rose
    Department of Urology, New York University School of Medicine, New York, New York 10016, USA
    J Transl Med 8:70. 2010
  8. ncbi request reprint Intermediate followup of hand assisted laparoscopic nephroureterectomy for urothelial carcinoma: factors associated with outcomes
    J Stuart Wolf
    Department of Urology, University of Michigan, Ann Arbor, USA
    J Urol 173:1102-7. 2005
  9. ncbi request reprint Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counseling
    Atreya Dash
    Department of Urology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
    Urology 64:117-22. 2004
  10. pmc Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate?
    Michael A Liss
    Department of Urology, University of California, Irvine, CA, USA
    Urology 82:67-71. 2013

Detail Information

Publications22

  1. doi request reprint The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor
    Atreya Dash
    Department of Urology and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 112:800-5. 2008
    ..The objectives of the current study were to determine the clinical outcome, patterns of relapse, and incidence of teratoma in the retroperitoneum for men with cIS NSGCT...
  2. ncbi request reprint Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm
    Atreya Dash
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BJU Int 97:939-45. 2006
    ..To compare the outcomes of patients who had a elective partial nephrectomy (PN) or radical nephrectomy (RN) for clear cell renal cell carcinoma (RCC) of 4-7 cm...
  3. ncbi request reprint Comorbidity and competing risks for mortality in men with prostate cancer
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, USA
    Cancer 117:4642-50. 2011
    ..The authors sought to assess the competing risks of nonprostate cancer and prostate cancer mortality among men with differing Charlson comorbidity index scores and tumor risks...
  4. pmc A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience
    Atreya Dash
    Division of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 113:2471-7. 2008
    ..Gemcitabine plus cisplatin (GC) has similar efficacy and less toxicity than MVAC in metastatic disease, but is untested as neoadjuvant treatment...
  5. doi request reprint Consideration of comorbidity in risk stratification prior to prostate biopsy
    Michael A Liss
    Department of Urology, University of California at Irvine, Irvine, California, USA
    Cancer 119:2413-8. 2013
    ..In the current study, the authors used these assessments to determine comorbidity and prognosis before prostate biopsy and the subsequent diagnosis of prostate cancer to identify those patients least likely to benefit from treatment...
  6. doi request reprint Improved prediction of long-term, other cause mortality in men with prostate cancer
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095 1738, USA
    J Urol 186:1868-73. 2011
    ..We identified long-term risks of other cause mortality associated with comorbidities in the Charlson index and applied these to the creation of a prostate cancer specific comorbidity index...
  7. pmc Copy number and gene expression differences between African American and Caucasian American prostate cancer
    Amy E Rose
    Department of Urology, New York University School of Medicine, New York, New York 10016, USA
    J Transl Med 8:70. 2010
    ....
  8. ncbi request reprint Intermediate followup of hand assisted laparoscopic nephroureterectomy for urothelial carcinoma: factors associated with outcomes
    J Stuart Wolf
    Department of Urology, University of Michigan, Ann Arbor, USA
    J Urol 173:1102-7. 2005
    ..We report our experience with hand assisted laparoscopic (HALS) nephroureterectomy and describe the associations of preoperative, operative and pathological factors with outcome...
  9. ncbi request reprint Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counseling
    Atreya Dash
    Department of Urology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
    Urology 64:117-22. 2004
    ..Homologous blood transfusion is sometimes required during or after RRP, but predictive models for estimating transfusion probability using patient and surgical characteristics are lacking...
  10. pmc Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate?
    Michael A Liss
    Department of Urology, University of California, Irvine, CA, USA
    Urology 82:67-71. 2013
    ..To investigate the performance of screening rectal cultures obtained 2 weeks before transrectal prostate biopsy to detect fluoroquinolone-resistant organisms and again at transrectal prostate biopsy...
  11. pmc Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery
    Atreya Dash
    Division of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Urology 72:641-6. 2008
    ..To determine whether socioeconomic factors affect prostate cancer outcomes, we studied a cohort of only black patients to minimize known confounding factors...
  12. pmc Endockscope: using mobile technology to create global point of service endoscopy
    William Sohn
    Department of Urology, University of California, Irvine, Orange, California 92862, USA
    J Endourol 27:1154-60. 2013
    ..We present our initial experience with Endockscope, a new docking system that optimizes the coupling of the iPhone 4S with modern endoscopes...
  13. ncbi request reprint Percutaneous treatment of renal cystic nephroma
    Atreya Dash
    Department of Urology, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Endourol 19:724-5. 2005
    ..When its presence is suspected preoperatively, nephron-sparing surgery can be applied. We describe treatment of a cystic nephroma that is the first reported, to our knowledge, using endoscopic techniques...
  14. doi request reprint Overtreatment of men with low-risk prostate cancer and significant comorbidity
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Cancer 117:2058-66. 2011
    ..Men with low-risk prostate cancer and significant comorbidity are susceptible to overtreatment. The authors sought to compare the impact of comorbidity and age on treatment choice in men with low-risk disease...
  15. ncbi request reprint Failure of percutaneous endoscopic resection of a renal cystic nephroma on longer-term follow-up
    J Stuart Wolf
    University of Michigan, Department of Urology, Ann Arbor, Michigan 48109 0330, USA
    J Endourol 22:1505-7. 2008
    ..Laparoscopic radical nephrectomy without adrenalectomy revealed benign cystic nephroma...
  16. ncbi request reprint Integrative analysis of genomic aberrations associated with prostate cancer progression
    Jung H Kim
    Michigan Center for Translational Pathology, Department of Pathology, Department of Urology, Program of Bioinformatics, and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109 0940, USA
    Cancer Res 67:8229-39. 2007
    ..Integrative analysis with matched mRNA profiles identified genetic alterations in several proposed candidate genes implicated in prostate cancer progression...
  17. ncbi request reprint A case of Castleman's disease that presented as a retroperitoneal mass
    Kinjal Vora
    Department of Surgery, Division of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Urol 4:285-8. 2007
    ..There were no aggravating or relieving factors for the left-flank pain and no other presenting symptoms, and the physical examination was unremarkable...
  18. ncbi request reprint Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder
    Atreya Dash
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 107:506-13. 2006
    ..Renal impairment may be a major factor limiting its use. The current study was designed to determine the proportion of patients ineligible to receive adjuvant cisplatin-based chemotherapy based on inadequate renal function alone...
  19. pmc Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens
    Atreya Dash
    Department of Urology, University of Michigan, Ann Arbor, USA
    Am J Pathol 161:1743-8. 2002
    ....
  20. pmc Holmium laser fulguration of superficial urothelial carcinoma of the pendulous urethra
    Michael A Liss
    Department of Urology, University of California Irvine and Long Beach Veterans Affairs Medical Center, Orange, CA, USA
    Indian J Urol 28:427-9. 2012
    ..The surgical approach was staged and provided excellent long term results for management of superficial UC...
  21. pmc Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy
    Michael A Liss
    Department of Urology, University of California Irvine, Irvine, California, USA
    J Urol 185:1283-8. 2011
    ..We estimated the prevalence of fluoroquinolone resistant Escherichia coli in patients undergoing repeat transrectal ultrasound guided prostate needle biopsy and identified high risk groups...
  22. ncbi request reprint Prostate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification. American Joint Committee on Cancer
    Atreya Dash
    Department of Urology, University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA
    Urology 60:276-80. 2002
    ..We therefore compared the recurrence risk in cases with bladder neck involvement with that of cases with extraprostatic extension and/or seminal vesicle invasion...